1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Naik, M.T. Huang, T.H. Shih, H. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Mol.Cell MOCEFL 2168 1097-2765 42 62 74 10.1016/j.molcel.2011.02.022 21474068 Structural and functional roles of Daxx SIM phosphorylation in SUMO paralog-selective binding and apoptosis modulation. 2011 11293.674 Small ubiquitin-related modifier 1 1 man polymer 2295.456 Death domain-associated protein 6 UNP residues 721-741 1 syn polymer SUMO-1, Sentrin, Ubiquitin-like protein SMT3C, SMT3 homolog 3, Ubiquitin-homology domain protein PIC1, Ubiquitin-like protein UBL1, GAP-modifying protein 1, GMP1 Daxx, hDaxx, Fas death domain-associated protein, ETS1-associated protein 1, EAP1 no no GSMSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPK ELGMEEEDVIEVYQEQTGG GSMSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPK ELGMEEEDVIEVYQEQTGG A polypeptide(L) no no GSKTSVATQCDPEEIIVLSDSD GSKTSVATQCDPEEIIVLSDSD B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample OK/SW-cl.43, SMT3C, SMT3H3, SUMO1, UBL1 9606 Homo sapiens 562 Escherichia coli BL21(DE3) pGex-4T1 This entry describes the solution structure of complex between Small Ubiquitin like Modifier -1 (SUMO-1) and the synthetic peptide derived from the C-terminal SUMO Interacting Motif (SIM) of Death Associated Protein -6. repository Initial release Version format compliance Database references 1 0 2010-12-01 1 1 2011-07-13 1 2 2013-08-21 Solution structure of complex between SUMO-1 and SIM from PIASx Solution structure of complex between SUMO-3 and SIM from MCAF1 BMRB Y PDBJ 2009-11-17 REL REL The peptide was chemically synthesized. The sequence of the peptide is naturally found in Homo sapiens (human) 9606 human Homo sapiens sample 2087 690 692 303 520 0 22 109 109 structures with the lowest energy 500 20 1 2D 1H-15N HSQC 2D 1H-13C HSQC 3D HNCA 3D HNCACB 3D CBCA(CO)NH 3D HNCO 3D 1H-15N TOCSY 3D HCCH-COSY 3D CCH-TOCSY 3D 1H-15N NOESY 3D 1H-13C NOESY 3D 1H-15N NOESY - F1 filtered 3D 1H-13C NOESY - F1 filtered 3D HNHA 2D 1H-15N HSQC - IPAP 0.27-0.5 mM [U-100% 15N] 0-1.7 mM 10 mM 100 mM 2 mM 0.1 mM 0.001 % 0.5 mM [U-100% 13C; U-100% 15N] 2 mM 10 mM 100 mM 2 mM 0.1 mM 0.001 % 2 mM 0.5 mM [U-100% 13C; U-100% 15N] 10 mM 100 mM 2 mM 0.1 mM 0.001 % 0.5 mM [U-100% 13C; U-100% 15N] 0.5 mM [U-100% 13C; U-100% 15N] 10 mM 100 mM 2 mM 0.1 mM 0.001 % 0.0066 w/v 0.1 6.5 ambient 290 K torsion angle dynamics 1 lowest energy 0.27-0.5mM [U-100% 15N] SUMO1-1, 0-1.7mM DAXX20-2, 10mM potassium phosphate-3, 100mM potassium chloride-4, 2mM DTT-5, 0.1mM EDTA-6, 0.001% sodium azide-7, 90% H2O/10% D2O 90% H2O/10% D2O 0.5 mM [U-100% 13C; U-100% 15N] SUMO1-8, 2mM DAXX20-9, 10mM potassium phosphate-10, 100mM potassium chloride-11, 2mM DTT-12, 0.1mM EDTA-13, 0.001% sodium azide-14, 90% H2O/10% D2O 90% H2O/10% D2O 2 mM SUMO1-15, 0.5mM [U-100% 13C; U-100% 15N] DAXX20-16, 10mM potassium phosphate-17, 100mM potassium chloride-18, 2mM DTT-19, 0.1mM EDTA-20, 0.001% sodium azide-21, 90% H2O/10% D2O 90% H2O/10% D2O 0.5mM [U-100% 13C; U-100% 15N] SUMO1-22, 0.5mM [U-100% 13C; U-100% 15N] DAXX20-23, 10mM potassium phosphate-24, 100mM potassium chloride-25, 2mM DTT-26, 0.1mM EDTA-27, 0.001% sodium azide-28, 0.0066 w/v Pf1 phage-29, 90% H2O/10% D2O 90% H2O/10% D2O BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,READ,RICE,SIMONSON,WARREN structure solution CNS 1.2 BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,READ,RICE,SIMONSON,WARREN refinement CNS 1.2 Linge, O'Donoghue and Nilges structure solution ARIA 2.2 Linge, O'Donoghue and Nilges refinement ARIA 2.2 Bruker Biospin processing TOPSPIN 2.1 Bruker Biospin collection TOPSPIN 2.1 Goddard peak picking SPARKY 3.113 Goddard chemical shift assignment SPARKY 3.113 500 Bruker Avance Bruker Avance 600 Bruker Avance Bruker Avance 800 Bruker Avance Bruker Avance n 1 -1 A n 2 0 A MET 1 n 3 MET 1 A SER 2 n 4 SER 2 A ASP 3 n 5 ASP 3 A GLN 4 n 6 GLN 4 A GLU 5 n 7 GLU 5 A ALA 6 n 8 ALA 6 A LYS 7 n 9 LYS 7 A PRO 8 n 10 PRO 8 A SER 9 n 11 SER 9 A THR 10 n 12 THR 10 A GLU 11 n 13 GLU 11 A ASP 12 n 14 ASP 12 A LEU 13 n 15 LEU 13 A GLY 14 n 16 GLY 14 A ASP 15 n 17 ASP 15 A LYS 16 n 18 LYS 16 A LYS 17 n 19 LYS 17 A GLU 18 n 20 GLU 18 A GLY 19 n 21 GLY 19 A GLU 20 n 22 GLU 20 A TYR 21 n 23 TYR 21 A ILE 22 n 24 ILE 22 A LYS 23 n 25 LYS 23 A LEU 24 n 26 LEU 24 A LYS 25 n 27 LYS 25 A VAL 26 n 28 VAL 26 A ILE 27 n 29 ILE 27 A GLY 28 n 30 GLY 28 A GLN 29 n 31 GLN 29 A ASP 30 n 32 ASP 30 A SER 31 n 33 SER 31 A SER 32 n 34 SER 32 A GLU 33 n 35 GLU 33 A ILE 34 n 36 ILE 34 A HIS 35 n 37 HIS 35 A PHE 36 n 38 PHE 36 A LYS 37 n 39 LYS 37 A VAL 38 n 40 VAL 38 A LYS 39 n 41 LYS 39 A MET 40 n 42 MET 40 A THR 41 n 43 THR 41 A THR 42 n 44 THR 42 A HIS 43 n 45 HIS 43 A LEU 44 n 46 LEU 44 A LYS 45 n 47 LYS 45 A LYS 46 n 48 LYS 46 A LEU 47 n 49 LEU 47 A LYS 48 n 50 LYS 48 A GLU 49 n 51 GLU 49 A SER 50 n 52 SER 50 A TYR 51 n 53 TYR 51 A CYS 52 n 54 CYS 52 A GLN 53 n 55 GLN 53 A ARG 54 n 56 ARG 54 A GLN 55 n 57 GLN 55 A GLY 56 n 58 GLY 56 A VAL 57 n 59 VAL 57 A PRO 58 n 60 PRO 58 A MET 59 n 61 MET 59 A ASN 60 n 62 ASN 60 A SER 61 n 63 SER 61 A LEU 62 n 64 LEU 62 A ARG 63 n 65 ARG 63 A PHE 64 n 66 PHE 64 A LEU 65 n 67 LEU 65 A PHE 66 n 68 PHE 66 A GLU 67 n 69 GLU 67 A GLY 68 n 70 GLY 68 A GLN 69 n 71 GLN 69 A ARG 70 n 72 ARG 70 A ILE 71 n 73 ILE 71 A ALA 72 n 74 ALA 72 A ASP 73 n 75 ASP 73 A ASN 74 n 76 ASN 74 A HIS 75 n 77 HIS 75 A THR 76 n 78 THR 76 A PRO 77 n 79 PRO 77 A LYS 78 n 80 LYS 78 A GLU 79 n 81 GLU 79 A LEU 80 n 82 LEU 80 A GLY 81 n 83 GLY 81 A MET 82 n 84 MET 82 A GLU 83 n 85 GLU 83 A GLU 84 n 86 GLU 84 A GLU 85 n 87 GLU 85 A ASP 86 n 88 ASP 86 A VAL 87 n 89 VAL 87 A ILE 88 n 90 ILE 88 A GLU 89 n 91 GLU 89 A VAL 90 n 92 VAL 90 A TYR 91 n 93 TYR 91 A GLN 92 n 94 GLN 92 A GLU 93 n 95 GLU 93 A GLN 94 n 96 GLN 94 A THR 95 n 97 THR 95 A GLY 96 n 98 GLY 96 A GLY 97 n 99 GLY 97 A n 1 719 B n 2 720 B LYS 721 n 3 LYS 721 B THR 722 n 4 THR 722 B SER 723 n 5 SER 723 B VAL 724 n 6 VAL 724 B ALA 725 n 7 ALA 725 B THR 726 n 8 THR 726 B GLN 727 n 9 GLN 727 B CYS 728 n 10 CYS 728 B ASP 729 n 11 ASP 729 B PRO 730 n 12 PRO 730 B GLU 731 n 13 GLU 731 B GLU 732 n 14 GLU 732 B ILE 733 n 15 ILE 733 B ILE 734 n 16 ILE 734 B VAL 735 n 17 VAL 735 B LEU 736 n 18 LEU 736 B SER 737 n 19 SER 737 B ASP 738 n 20 ASP 738 B SER 739 n 21 SER 739 B ASP 740 n 22 ASP 740 B author_defined_assembly 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O ILE 34 A O ILE 36 A N VAL 26 A N VAL 28 A N LYS 25 A N LYS 27 A O ILE 88 A O ILE 90 A O TYR 91 A O TYR 93 A N ARG 63 A N ARG 65 A N PHE 66 A N PHE 68 A O GLN 69 A O GLN 71 1 A GLY -1 A GLY 1 1 Y 1 A SER 0 A SER 2 1 Y 1 B GLY 719 B GLY 1 1 Y 1 B SER 720 B SER 2 1 Y 2 A GLY -1 A GLY 1 1 Y 2 A SER 0 A SER 2 1 Y 2 B GLY 719 B GLY 1 1 Y 2 B SER 720 B SER 2 1 Y 3 A GLY -1 A GLY 1 1 Y 3 A SER 0 A SER 2 1 Y 3 B GLY 719 B GLY 1 1 Y 3 B SER 720 B SER 2 1 Y 4 A GLY -1 A GLY 1 1 Y 4 A SER 0 A SER 2 1 Y 4 B GLY 719 B GLY 1 1 Y 4 B SER 720 B SER 2 1 Y 5 A GLY -1 A GLY 1 1 Y 5 A SER 0 A SER 2 1 Y 5 B GLY 719 B GLY 1 1 Y 5 B SER 720 B SER 2 1 Y 6 A GLY -1 A GLY 1 1 Y 6 A SER 0 A SER 2 1 Y 6 B GLY 719 B GLY 1 1 Y 6 B SER 720 B SER 2 1 Y 7 A GLY -1 A GLY 1 1 Y 7 A SER 0 A SER 2 1 Y 7 B GLY 719 B GLY 1 1 Y 7 B SER 720 B SER 2 1 Y 8 A GLY -1 A GLY 1 1 Y 8 A SER 0 A SER 2 1 Y 8 B GLY 719 B GLY 1 1 Y 8 B SER 720 B SER 2 1 Y 9 A GLY -1 A GLY 1 1 Y 9 A SER 0 A SER 2 1 Y 9 B GLY 719 B GLY 1 1 Y 9 B SER 720 B SER 2 1 Y 10 A GLY -1 A GLY 1 1 Y 10 A SER 0 A SER 2 1 Y 10 B GLY 719 B GLY 1 1 Y 10 B SER 720 B SER 2 1 Y 11 A GLY -1 A GLY 1 1 Y 11 A SER 0 A SER 2 1 Y 11 B GLY 719 B GLY 1 1 Y 11 B SER 720 B SER 2 1 Y 12 A GLY -1 A GLY 1 1 Y 12 A SER 0 A SER 2 1 Y 12 B GLY 719 B GLY 1 1 Y 12 B SER 720 B SER 2 1 Y 13 A GLY -1 A GLY 1 1 Y 13 A SER 0 A SER 2 1 Y 13 B GLY 719 B GLY 1 1 Y 13 B SER 720 B SER 2 1 Y 14 A GLY -1 A GLY 1 1 Y 14 A SER 0 A SER 2 1 Y 14 B GLY 719 B GLY 1 1 Y 14 B SER 720 B SER 2 1 Y 15 A GLY -1 A GLY 1 1 Y 15 A SER 0 A SER 2 1 Y 15 B GLY 719 B GLY 1 1 Y 15 B SER 720 B SER 2 1 Y 16 A GLY -1 A GLY 1 1 Y 16 A SER 0 A SER 2 1 Y 16 B GLY 719 B GLY 1 1 Y 16 B SER 720 B SER 2 1 Y 17 A GLY -1 A GLY 1 1 Y 17 A SER 0 A SER 2 1 Y 17 B GLY 719 B GLY 1 1 Y 17 B SER 720 B SER 2 1 Y 18 A GLY -1 A GLY 1 1 Y 18 A SER 0 A SER 2 1 Y 18 B GLY 719 B GLY 1 1 Y 18 B SER 720 B SER 2 1 Y 19 A GLY -1 A GLY 1 1 Y 19 A SER 0 A SER 2 1 Y 19 B GLY 719 B GLY 1 1 Y 19 B SER 720 B SER 2 1 Y 20 A GLY -1 A GLY 1 1 Y 20 A SER 0 A SER 2 1 Y 20 B GLY 719 B GLY 1 1 Y 20 B SER 720 B SER 2 1 Y 1 A A HZ1 OE1 LYS GLU 46 49 1.59 1 A B HZ2 OD2 LYS ASP 39 740 1.59 2 A B HD3 HG13 ARG ILE 54 733 1.10 2 A B HG2 HB3 LYS ASP 39 740 1.27 2 A A HZ3 OE1 LYS GLU 23 84 1.54 3 A B HD3 HG12 ARG ILE 54 733 1.31 3 A A HD1 OE1 HIS GLU 75 79 1.57 3 A A O HZ2 TYR LYS 21 37 1.59 4 A A HD1 HD2 TYR LYS 21 37 1.26 4 A B HE21 HD11 GLN ILE 55 733 1.33 4 A B HG OE1 SER GLU 32 731 1.59 5 A A HA HB2 MET GLU 1 5 1.21 5 A B HG2 HB2 LYS ASP 39 738 1.25 5 A A HE OE2 ARG GLU 63 93 1.58 6 A A HZ2 HH LYS TYR 17 21 1.32 7 A A HE2 HB2 PHE SER 36 50 1.22 7 A B HD3 HG13 ARG ILE 54 733 1.28 8 A A HB2 HE21 ASP GLN 3 4 1.22 8 A B HD3 HG12 ARG ILE 54 733 1.33 8 A A OD1 H ASP GLN 3 4 1.56 9 A A HD1 OE1 HIS GLU 75 79 1.59 10 A A HD3 HB3 LYS HIS 23 35 1.31 11 A B HG2 HB3 LYS ASP 39 740 1.27 11 A A HD1 OE1 HIS GLU 75 79 1.59 12 A A OD2 HZ1 ASP LYS 12 16 1.60 13 A B HZ3 OD1 LYS ASP 39 738 1.51 13 A A HZ3 OD1 LYS ASP 45 73 1.54 13 A A O HG ASP SER 30 31 1.59 13 A A HZ3 OE2 LYS GLU 48 93 1.60 14 A B HD3 HG13 ARG ILE 54 733 1.26 15 A B HD3 HG12 ARG ILE 54 733 1.29 15 A B HD2 HB2 LYS ASP 39 738 1.31 16 A B HD3 HG13 ARG ILE 54 733 1.32 16 A A HZ1 OE2 LYS GLU 37 84 1.56 18 A A HZ2 HH LYS TYR 17 21 0.97 18 A B HD3 HG13 ARG ILE 54 733 1.25 19 A B HD3 HG12 ARG ILE 54 733 1.28 20 A B HD3 HG13 ARG ILE 54 733 1.13 19 A TYR 51 0.051 SIDE CHAIN 7 A A CE1 CZ TYR TYR 91 91 -0.082 0.013 1.381 1.299 N 1 A GLN 4 -125.79 -91.92 1 A ASP 12 -128.17 -59.70 1 A LYS 16 -74.94 -95.39 1 A LYS 17 -114.35 -94.60 1 A SER 31 74.54 -0.89 1 B PRO 730 -85.92 -149.17 2 A GLN 4 -99.41 32.91 2 A PRO 8 -88.60 37.48 2 A LYS 16 -116.02 -80.54 2 A LYS 17 -101.05 -93.48 2 A GLU 18 -179.39 -172.54 2 A GLN 94 -131.39 -159.03 3 A SER 2 -84.30 -80.67 3 A GLN 4 -113.25 -87.05 3 A GLU 5 -110.00 -68.92 3 A PRO 8 -79.63 31.31 3 A ASP 12 -93.84 32.99 3 A SER 31 68.53 -15.22 3 A GLN 94 -140.67 -159.48 4 A ASP 3 -129.42 -76.92 4 A PRO 8 -72.34 43.54 4 A GLU 11 -76.48 24.93 4 A LYS 17 -96.43 -71.92 4 A GLN 94 -132.69 -157.12 4 B PRO 730 -61.03 -165.78 5 A SER 2 -76.15 -95.09 5 A PRO 8 -81.81 32.88 5 A LYS 17 -87.12 -75.39 5 A ARG 70 -58.48 109.18 5 B PRO 730 -75.38 -159.82 6 A LYS 7 -38.06 118.37 6 A SER 9 -140.41 11.48 6 A THR 10 -137.37 -68.61 6 A LYS 17 -102.00 -62.74 6 A SER 31 71.97 -0.62 6 A GLN 94 -120.91 -169.23 7 A PRO 8 -73.38 46.46 7 A LYS 17 -102.14 -94.78 7 A SER 31 72.53 -5.87 7 A GLN 94 -114.12 -160.92 7 B PRO 730 -78.24 -156.21 8 A ASP 3 -111.28 -77.31 8 A GLN 4 -125.88 -55.60 8 A ASP 12 -90.45 32.43 8 A LYS 16 -88.19 -82.94 8 A SER 31 71.78 -11.58 9 A THR 10 -80.55 -75.41 9 A ASP 15 -125.92 -51.69 9 A LYS 17 -90.57 -87.18 9 A GLN 94 -163.50 -155.56 10 A SER 2 -101.84 -69.31 10 A ASP 3 -130.40 -65.44 10 A PRO 8 -85.35 49.44 10 A LYS 17 -47.74 -94.56 10 A SER 31 78.45 -15.12 10 A GLN 94 -125.03 -154.91 11 A PRO 8 -94.56 43.82 11 A THR 10 -139.18 -72.97 11 A GLU 11 -132.12 -81.41 11 A LEU 13 -66.67 -179.72 11 A LYS 17 -61.28 -77.64 11 A GLN 94 -136.70 -156.31 12 A GLU 5 -90.88 44.02 12 A ALA 6 -65.75 -173.29 12 A SER 31 69.27 -5.52 12 A THR 41 -105.51 40.91 12 A GLN 94 -114.75 -163.20 12 B PRO 730 -69.70 27.34 13 A PRO 8 -90.08 40.49 13 A LYS 17 -76.03 -71.81 13 A SER 31 73.17 -2.34 13 A GLN 94 -120.96 -161.62 13 B PRO 730 -80.73 -158.05 14 A ASP 12 -89.88 35.54 14 A SER 31 76.67 -10.91 14 A GLN 94 -138.71 -152.24 14 A THR 95 -34.80 -156.89 15 A PRO 8 -83.85 44.50 15 A LEU 13 -68.47 -177.28 15 A GLN 94 -123.03 -164.63 16 A SER 9 -140.41 14.94 16 A THR 10 -126.45 -71.07 16 A LYS 17 -73.06 -79.58 16 A SER 31 73.76 -0.96 16 A GLN 94 -121.17 -156.13 17 A GLN 4 -69.95 -70.39 17 A GLU 5 -132.59 -78.08 17 A PRO 8 -91.82 30.02 17 A ASP 12 -92.79 32.67 17 A LYS 16 -78.96 -86.94 17 A SER 31 80.32 -15.07 17 A GLU 85 80.11 19.84 17 A GLN 94 -129.26 -163.83 17 B PRO 730 -77.14 -158.91 18 A ALA 6 -69.87 93.16 18 A PRO 8 -98.01 41.64 18 A LYS 17 -49.96 -81.49 18 A GLN 94 -158.07 -159.87 19 A SER 2 -75.41 -81.02 19 A ASP 3 -129.50 -87.99 19 A GLN 4 -124.97 -84.50 19 A GLU 5 -109.37 42.69 19 A LYS 17 -27.97 -60.12 19 A SER 31 75.27 -14.85 19 A GLN 94 -118.89 -161.72 20 A SER 2 -123.60 -93.83 20 A GLN 4 -115.05 -87.54 20 A GLU 5 -132.45 -82.64 20 A LYS 16 -112.99 -94.65 20 A GLU 18 -124.81 -164.06 20 A SER 31 75.64 -4.76 20 A GLN 94 -100.59 -155.68 20 B PRO 730 -79.56 -166.48 Small ubiquitin-related modifier 1, Death domain-associated protein 6 lowest energy, model 1 Phosphorylation of SUMO-interacting motif by CK2 enhances Daxx SUMO binding activity 1 N N 2 N N A HIS 43 A HIS 45 HELX_P A GLY 56 A GLY 58 1 1 14 A THR 76 A THR 78 HELX_P A GLY 81 A GLY 83 1 2 6 TRANSCRIPTION, APOPTOSIS SUMO, SIM, Daxx, Nucleus, Phosphoprotein, Ubl conjugation pathway, Apoptosis, Transcription, Transcription regulation SUMO1_HUMAN UNP 1 1 P63165 MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKEL GMEEEDVIEVYQEQTGG DAXX_HUMAN UNP 2 721 Q9UER7 KTSVATQCDPEEIIVLSDSD 1 97 2KQS 1 97 P63165 A 1 3 99 721 740 2KQS 721 740 Q9UER7 B 2 3 22 1 EXPRESSION TAG GLY -1 2KQS A P63165 UNP 1 1 EXPRESSION TAG SER 0 2KQS A P63165 UNP 2 2 EXPRESSION TAG GLY 719 2KQS B Q9UER7 UNP 1 2 EXPRESSION TAG SER 720 2KQS B Q9UER7 UNP 2 5 anti-parallel parallel anti-parallel anti-parallel A GLU 33 A GLU 35 A VAL 38 A VAL 40 A ILE 22 A ILE 24 A ILE 27 A ILE 29 A ASP 86 A ASP 88 A GLN 92 A GLN 94 A LEU 62 A LEU 64 A PHE 66 A PHE 68 A GLN 69 A GLN 71 A ARG 70 A ARG 72